These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 7772289)
1. Forty years of screening programmes for antibiotics. Mochales S Microbiologia; 1994 Dec; 10(4):331-42. PubMed ID: 7772289 [TBL] [Abstract][Full Text] [Related]
2. Screening antibiotics: industrial research by CEPA and Merck in the 1950s. Jesús Santesmases M Dynamis; 2011; 31(2):407-27. PubMed ID: 22332466 [TBL] [Abstract][Full Text] [Related]
3. [Antibacterial effect of N-formimidoyl-thienamycin in combination with amikacin, cefoxitin and fosfomycin on K. pneumoniae and P. aeruginosa]. Schröter G; Schrettenbrunner A Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Dec; 253(3):355-7. PubMed ID: 6820589 [No Abstract] [Full Text] [Related]
4. Screening strategies for discovery of antibacterial natural products. Singh SB; Young K; Miesel L Expert Rev Anti Infect Ther; 2011 Aug; 9(8):589-613. PubMed ID: 21819327 [TBL] [Abstract][Full Text] [Related]
5. Evolution of an antibiotic screening programme. A tribute to Justo Martinez Mata. Woodruff HB; Hernandez S; Stapley EO Hindustan Antibiot Bull; 1979 Feb; 21(3):71-84. PubMed ID: 396280 [No Abstract] [Full Text] [Related]
6. The historical delivery of antibiotics from microbial natural products--can history repeat? Peláez F Biochem Pharmacol; 2006 Mar; 71(7):981-90. PubMed ID: 16290171 [TBL] [Abstract][Full Text] [Related]
7. Establishment and validation of a 384-well antibacterial assay amenable for high-throughput screening and combination testing. Mishra A; Dobritsa SV; Crouch ML; Rabenstein J; Lee JX; Dhakshinamoorthy S J Microbiol Methods; 2015 Nov; 118():173-5. PubMed ID: 26432950 [TBL] [Abstract][Full Text] [Related]
8. [Methodology of Screening New Antibiotics: Present Status and Prospects]. Trenin AS Antibiot Khimioter; 2015; 60(7-8):34-46. PubMed ID: 26863741 [TBL] [Abstract][Full Text] [Related]
9. [Fosfomycin: past, present and future]. Baylan O Mikrobiyol Bul; 2010 Apr; 44(2):311-21. PubMed ID: 20549968 [TBL] [Abstract][Full Text] [Related]
10. Non-antibiotics--drugs with additional antimicrobial activity. Tyski S Acta Pol Pharm; 2003; 60(5):401-4. PubMed ID: 15005425 [TBL] [Abstract][Full Text] [Related]
11. [Antibacterial activity of fosfomycin. II. Determination of minimal bactericidal concentration in association with other antibiotics]. Grassi GG; Ferrara A; Navone A; Peona V; Sala P G Ital Chemioter; 1977; 23(2):87-94. PubMed ID: 606614 [No Abstract] [Full Text] [Related]
12. Producing standards, producing the Nordic region: antibiotic susceptibility testing, from 1950-1970. Lie AK Sci Context; 2014 Jun; 27(2):215-48. PubMed ID: 24941790 [No Abstract] [Full Text] [Related]
13. Development of antibiotic activity profile screening for the classification and discovery of natural product antibiotics. Wong WR; Oliver AG; Linington RG Chem Biol; 2012 Nov; 19(11):1483-95. PubMed ID: 23177202 [TBL] [Abstract][Full Text] [Related]
14. [Biological method of identifying antibiotic substances at an early screening stage]. Tikhonova AS; Chaĭkovskaia SM; Rezvan SP; Elizarova RN; Florova VI Antibiotiki; 1978 Aug; 23(8):677-82. PubMed ID: 686689 [TBL] [Abstract][Full Text] [Related]
19. Cephalosporin, thienamycin, and monobactam antibiotics: a review of antimicrobial activity, pharmacology, and safety. Smith BR; LeFrock JL J Foot Surg; 1987; 26(1 Suppl):S42-50. PubMed ID: 3549852 [No Abstract] [Full Text] [Related]
20. [Soviet research on finding and studying antibiotics and other biologically active substances of natural origin]. Sobolev VR; Ved'mina EA Antibiotiki; 1977 Oct; 22(10):870-8. PubMed ID: 335953 [No Abstract] [Full Text] [Related] [Next] [New Search]